Category: News
-
Rising Measles Cases in the United States
A Dangerous Resurgence Measles, once declared eliminated in the United States in 2000, has roared back in 2025 with a vengeance. The Centers for Disease Control and Prevention (CDC) reports 1,681 confirmed cases this year, a staggering increase from 285 in 2024. This marks the highest annual total since the early 1990s. The virus has
-
Why More Americans Are Ditching Traditional Health Care for New Models in 2026
A Healthcare Revolution in Motion Across the United States, the way people find and experience health care is changing dramatically. Long gone are the days when nearly everyone relied on the familiar duo of a family doctor’s office and hospital networks, with insurance cards always at the ready. In their place, innovative – and sometimes
-
FDA Recalls 141,984 Bottles of Atorvastatin Calcium After Failed Dissolution Testing
On 10 October 2025 the U.S. Food and Drug Administration (FDA) classified a nationwide recall of Atorvastatin Calcium tablets, initiated by Ascend Laboratories, LLC, as a Class II recall because multiple lots “failed dissolution specifications,” affecting 141,984 bottles distributed across the United States. The recalled product is a generic formulation of atorvastatin (a statin widely
-
The ANDA Prioritization Pilot Is a Smart, Strategic Move to Rebuild U.S. Generic Drug Manufacturing Capacity
The Food and Drug Administration’s new ANDA Prioritization Pilot realigns regulatory incentives to reward onshore bioequivalence testing and U.S. manufacturing of finished dosage forms and active pharmaceutical ingredients (API), and it will strengthen supply‑chain resilience, lower inspection costs, and speed patient access to affordable generics. The policy leverages FDA review speed as a targeted market
-
Acetaminophen Use During Pregnancy Has No Credible Link to Autism
Acetaminophen, widely recognized under the brand name Tylenol®, is the most commonly recommended over-the-counter (OTC) analgesic and antipyretic for pregnant women. For decades, both regulatory agencies and medical professionals have considered it the safest option for managing pain and fever during pregnancy, especially given the well-documented risks associated with alternatives such as NSAIDs and opioids.